Staff: Mirjana Djordjevic, Ph.D.
Mirjana Djordjevic, Ph.D.
Mirjana Djordjevic, Ph.D., is currently a Health Scientist Administrator in the Tobacco Control Research Branch within the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). Dr. Djordjevic serves as a Program Director and Project Officer managing extramural research in various areas of tobacco control, including grants in tobacco regulatory science funded by the FDA's Center for Tobacco Products. She played a key role in the development and implementation of several funding initiatives aimed at fostering research on tobacco products, including the Program Announcement, "Testing Tobacco Products Promoted to Reduce Harm," and the Research and Development Contract, "Laboratory Assessment of Tobacco Use Behavior and Exposure to Toxins among Users of New Tobacco Products Promoted to Reduce Harm."
Dr. Djordjevic is a member of the World Health Organization's Study Group on Tobacco Product Regulation (TobReg) and Tobacco Laboratory Network (TobLabNet). In the latter capacity, she works together with other scientists—with a background on product regulation, tobacco dependence treatment, and laboratory testing of tobacco contents, emissions, and product design features—on developing research and policy recommendations and advisory notes on a wide range of topics to inform policy and regulation.
Because of her expertise in tobacco and tobacco smoke chemistry, biochemistry, biomarkers, and bio-behavioral aspects of use of tobacco products, Dr. Djordjevic had served for four years as an Ex Officio member of the FDA Tobacco Products Scientific Advisory Committee (TPSAC) representing National Institutes of Health. In the latter role, Dr. Djordjevic also served as a member of the Tobacco Products Constituents Subcommittee which developed a list of harmful and potentially harmful constituents (HPHC) for regulation.
Dr. Djordjevic joined NCI in 2001 as an expert on tobacco products. Prior to joining NCI, Dr. Djordjevic worked at the former American Health Foundation, Valhalla, New York, one of the NCI's Comprehensive Cancer Centers. Dr. Djordjevic received a doctorate in organic geochemistry from the University of Belgrade, College of Natural and Mathematical Sciences, Belgrade, Serbia.
- Tobacco products chemical composition and design
- Novel tobacco products
- Use behavior and smoking topography
- Methods for chemical and toxicological testing
- Biomarkers of exposure to nicotine and other tobacco and smoke toxicants
Selected Publications and Presentations
- Song, M.A., Marian, C., Brasky, T.M., Reisinger, S., Djordjevic, M., & Shields, P.G. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products. Toxicol Lett 2016; 245:68-77.
- Berman, M.L., Connolly, G., Cummings, K.M., Djordjevic, M.V., Hatsukami, D.K., Henningfield, J.E., Myers, M., O'Connor, R.J., Parascandola, M., Rees, V., Rice, J.M., & Shields, P.G. Providing a Science Base for the Evaluation of Tobacco Products. Tob Reg Sci 2015; 1(1):76-93.
- Walton, K.M., Abrams, D.B., Bailey, W.C., Clark, D., Connolly, G.N., Djordjevic, M.V., Eissenberg, T.E., Fiore, M.C., Goniewicz, M.L., Haverkos, L., Hecht, S.S., Henningfield, J.E., Hughes, J.R., Oncken, C.A., Postow, L., Rose, J.E., Wanke, K.L., Yang, L., & Hatsukami, D.K. NIH electronic cigarette workshop: developing a research agenda. Nicotine Tob Res 2015; 17(2):259-269.
- Marian, C., O'Connor, R. J., Djordjevic, M. V., Rees, V. W., Hatsukami, D. K., & Shields, P. G. Reconciling human smoking behavior and machine smoking patterns: Implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev 2009; 18(12):3305-3320.
- Burns, D.M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., O'Connor, R., Djordjevic, M., Dresler, C., Hainaut, P., Jarvis, M., Opperhuizen, A., & Straif, K. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Reg Sci 2008; 17(2):132-141.